These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12596480)

  • 1. [Breaking down barriers--about the art of escorting drugs into the brain].
    Kahl U
    Lakartidningen; 2003 Jan; 100(3):136-7. PubMed ID: 12596480
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug targeting. Breaking down barriers.
    Miller G
    Science; 2002 Aug; 297(5584):1116-8. PubMed ID: 12183610
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
    Ganta S; Deshpande D; Korde A; Amiji M
    Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V; Lee TY
    Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery.
    Adenot M; Merida P; Lahana R
    Chemotherapy; 2007; 53(1):73-6. PubMed ID: 17202815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New methods of drug delivery through the blood brain barrier].
    Bruhn C
    Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
    Dilnawaz F; Sahoo SK
    Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles for targeted brain drug delivery.
    Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
    Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of solid lipid nanoparticles in brain targeting.
    Kaur IP; Bhandari R; Bhandari S; Kakkar V
    J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
    Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
    J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.